President Prioritizes Funding to End the HIV Epidemic in the U.S. FY 2023 Budget Plan
In his budget plan for fiscal year 2023, President Joe Biden calls for important investments to grow the Ending the HIV Epidemic initiative and to create a National PrEP Program that will dramatically increase access to PrEP and reach many more of the 1.2 million people who could benefit from it.
HIVMA Applauds President’s Budget to Create National PrEP Program
HIVMA applauds President Biden for calling for the creation of a national PrEP program with an investment of $9.8 billion in mandatory funding over 10 years in his fiscal year 2023 budget proposal.
HIVMA: Florida’s “Parental Rights” Bill Will Harm Health of LGBTQ Youth
HIVMA is deeply concerned by the harm that the “Parental Rights in Education” bill passed today by the Florida legislature will have on the health and quality of life of LGBTQ youth and families if signed into law.
IDSA and HIVMA Oppose Government Interference in Health Care Providers’ Ability to Provide Evidence-based Care
IDSA and HIVMA strongly urge Texas Gov. Greg Abbott to stop government interference in the patient-health care provider relationship by withdrawing the order released last week that classifies medical treatment provided to transgender youth as “child abuse.”
Recommendations for Ensuring Equitable Access to Oral Therapies for Treating COVID-19
IDSA and HIVMA recommendations for states and local jurisdictions to consider in determining the allocation of the limited supplies of COVID-19 antiviral pills.
HIVMA Chair Marwan Haddad, MD, MPH, Response to the National HIV/AIDS Strategy 2022 to 2025
On this World AIDS Day, HIVMA welcomes the release of the Biden-Harris Administration’s 2022 National HIV/AIDS Strategy, which will provide an important road map for ending HIV as an epidemic in the United States.
IDSA and HIVMA Support BIO Preparedness Workforce Act
IDSA and HIVMA applaud the bipartisan introduction of the Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act by Reps. Lori Trahan (D-MA) and David McKinley (R-WV), H.R. 5602, and its inclusion in an Oct. 26 Energy and Commerce Health Subcommittee hearing.
HIVMA Recognizes Excellence in HIV Clinical Education and Research with 2021 Awards
Recognizing preeminent contributions to the field of HIV medicine in clinical education and research, the HIV Medicine Association (HIVMA) presented its 2021 Awards for Excellence to Roger Bedimo, MD, MS, FIDSA, and Colleen Kelley, MD, MPH during IDWeek 2021.
HIVMA Names Marwan S. Haddad, MD, MPH, as Chair of its Board of Directors
New board members affirm commitment to work to address health disparities and end the HIV epidemic. The HIV Medicine Association is pleased to announce the election of a vice chair and three new members to its Board of Directors and to name Marwan S. Haddad, MD, MPH, as its new chair.
IDSA and HIVMA Call for Greater U.S. Leadership in Accelerating Global Vaccine Equity
IDSA and its HIVMA support the Biden Administration’s call for new global commitments to control the COVID-19 pandemic and applaud the Administration’s initial steps of donating vaccine doses and making financial contributions to COVAX, the COVID-19 Vaccines Global Access initiative.
Infectious Diseases Professionals: Eliminating Viral Hepatitis ‘Ambitious but Achievable’ Goal
As scientific and political leaders commemorate World Hepatitis Day, infectious diseases professionals call on policymakers to support the updated National Viral Hepatitis Strategic Plan that aims to eliminate viral hepatitis as a public health threat in the United States.
Major Health Care Professional Organizations Call for COVID-19 Vaccine Mandates for All Health Workers
IDSA and HIVMA joined more than 50 health care professional organizations in calling for requiring COVID-19 vaccinations for all health care workers.